 VALENCIA, Calif. and MELBOURNE, Australia, Jan. 19, 2023 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH AVITA Medical or the Company, a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today changes to its management structure designed to advance its strategic growth plans and accelerate execution under recently appointed Chief Executive Officer, James Corbett. To align with AVITA Medicals new operating structure, the following organizational changes will be effective January 19, 2023: 